Ferring Pharmaceuticals
Clinical trials sponsored by Ferring Pharmaceuticals, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Real-World REKOVELLE study targets IVF success in asian women Results expected May 2027 (estimated)
-
Can a gene therapy instilled in the bladder fight tough bladder cancer?
Disease control OngoingThis trial tests a gene therapy called FE 999326 (nadofaragene firadenovec) in Japanese patients with high-grade non-muscle invasive bladder cancer that has not responded to BCG treatment. The therapy is given as a liquid instilled into the bladder through a catheter every three …
Phase 3 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Real-World REKOVELLE study targets IVF success in asian women
Knowledge-focused OngoingThis study follows 1,500 Asian women using REKOVELLE for the first time during IVF to see how well it works in everyday medical practice. Researchers will track live birth rates and how the drug is used. The goal is to understand its real-world effectiveness and safety for this s…
Sponsor: Ferring Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Fertility drug delivery study pulled before it began
Knowledge-focused CancelledThis study was designed to see how a hormone called GnRH is processed by the body when given through a small pump (OmniPod) instead of a needle. It was meant for healthy women aged 18 to 40 with regular periods. However, the trial was withdrawn before any participants were enroll…
Phase 1 • Sponsor: Ferring Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC